Speaker illustration

Doctor Rahul Aggarwal

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

Applicability of VICTORION-1 PREVENT Criteria to the US Population

Event: ESC Congress 2024

Topic: Epidemiology

Session: Epidemiology of cardiovascular risk and disease

Thumbnail

Cardiovascular risk factors and disease mortality among asian american subgroups

Event: ESC Congress 2024

Topic: Public Health

Session: Mapping cardiovascular health: risk factors, interventions, and geographic insights

Thumbnail

Icosapent ethyl by baseline small dense low-density lipoprotein cholesterol: an analysis of REDUCE-IT

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Identification and risk stratification of relevant coronary artery disease in clinical practice

Thumbnail

Efficacy of sotagliflozin by diabetes duration: a secondary analysis of SCORED

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Drug therapy for heart failure: what is new?

Thumbnail

Development and validation of the DOAC Score: a novel bleeding risk prediction tool for patients with atrial fibrillation

Event: ESC Congress 2023

Topic: Oral Anticoagulation

Session: Stroke and bleeding risk in atrial fibrillation: walking the tight rope

Thumbnail